Danaher Corp /De/ - Jun 17, 2021 Form 3/A - restatement Insider Report for Codex DNA, Inc. (TBIO)

Role
10%+ Owner
Signature
Danaher Corporation /s/ James F. O'Reilly, Vice President, Deputy General Counsel and Secretary
Stock symbol
TBIO
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
3/A - RESTATEMENT
Date filed
6/24/2021, 04:50 PM
Date Of Original Report
Jun 17, 2021
Next filing
Jun 24, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TBIO Series A Preferred Stock Jun 17, 2021 Common Stock 1,751,999 By Danaher Innovation Center LLC F1, F2
holding TBIO Series A-1 Preferred Stock Jun 17, 2021 Common Stock 542,158 By Danaher Innovation Center LLC F1, F2

Explanation of Responses:

Id Content
F1 All shares of the preferred stock, par value $0.0001 per share, of the Issuer will automatically be converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), prior to the closing of the Issuer's initial public offering of its Common Stock.
F2 Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037.